Filing Flows

Filing Flows › Phibro Animal Health (PAHC) › Q4 FY25

Phibro Animal Health (PAHC) Q4 FY25 earnings results (fourth quarter fiscal 2025)

10-K filed Aug 27, 2025

Phibro Animal Health (PAHC) reported revenue of $379M for the fourth quarter fiscal 2025 (Q4 FY25), +39% from a year earlier and +9% from the quarter before. Operating margin was 8.9%, net earnings $17.2M (4.5% of revenue).

Revenue$379M
Year over year+39%
Quarter over quarter+9%
Operating margin8.9%
Net earnings$17.2M

Phibro Animal Health, Q4 FY25: revenue $379M (+39% year over year), operating margin 8.9%, net earnings $17.2M, operating cash flow $21.3M. The chart follows the revenue to costs, profit and cash.

Q4 FY25AmountQ/QY/Y
Revenue$379M+9%+39%
Gross profit$110M+5%+26%
Operating profit$33.7M+0.6%+83%
Net earnings$17.2M-18%23×
Operating cash flow$21.3M-51%-25%
Free cash flow$8.1M-77%-47%

What changed

Revenue was $378.7M in Q4 FY25, up 39% year over year and up 9% from the previous quarter. MFAs and other was the largest line at 55% of revenue.

Gross margin was 29.0%, down 2.9 points from a year earlier. Operating profit was $33.7M, a 8.9% margin (up 2.2 points year over year). Of the extra revenue versus a year earlier, 14% reached operating profit, above the 7% margin then. Operating expenses grew 11% against revenue growth of 39%. Net earnings were $17.2M, up 2190% year over year. The effective tax rate was 27.8%.

Operating cash flow was $21.3M (down 25% year over year), 124% of net earnings. Non-cash charges added back $12.4M of depreciation and amortization and $179K of share-based compensation. Working capital and other items used $8.5M. Capital expenditures of $13.1M left free cash flow of $8.1M.

Questions

What was Phibro Animal Health's revenue in the fourth quarter fiscal 2025?

Phibro Animal Health (PAHC) reported revenue of $379M for the fourth quarter fiscal 2025 (Q4 FY25), +39% from a year earlier and +9% from the quarter before.

Was Phibro Animal Health profitable in the fourth quarter fiscal 2025?

Operating profit was $33.7M (8.9% of revenue) and net earnings $17.2M.

Open the interactive Sankey →

Source: Phibro Animal Health 10-K on SEC EDGAR.